Study of gastrointestinal electrical stimulation in the treatment of functional constipation in Parkinson's disease

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050714

Enrollment

Unknown

Registered

2021-09-03

Start date

2021-09-10

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

experimental group:Gastrointestinal stimulator therapy

control group:Conventional treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of PD in the "Diagnostic Criteria for Parkinson's Disease in China (2016 Edition)"; 2. PDH-Y (modified) grading scale <= grade 3; 3. Associated with constipation, and meet the diagnostic criteria of Rome III for constipation; 4. Age 45-75 years.

Exclusion criteria

Exclusion criteria: 1. Suffering from gastrointestinal tumors, gastrointestinal bleeding and other serious gastrointestinal diseases; 2. Combined with serious heart, lung, kidney and other diseases; 3. Install a pacemaker; 4. Those who have used cathartic and prokinetic drugs within 24 hours; 5. Patients with advanced tumor; 6. Those who are participating in other clinical trials; 7. Patients who refuse to participate in the study.

Design outcomes

Primary

Measure	Time frame
Wexner Constipation scoring System;Number of bowel movements per week;	—

Secondary

Measure	Time frame
Cleveland constipation score;Constipation patients quality of life scale;Parkinson’s patients quality of life questionnaire;Changes in motilin, gastrin, vasoactive intestinal peptide and cholecystokinin levels;	—

Countries

China

Contacts

Public ContactYin Jiangtao

The Affiliated Hospital of Jiangsu University

doctoryjt2438@163.com+86 13952943135

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026